Deoderm Gel Dressing with Hyaluronic Acid

DEODERM by

Drug Labeling and Warnings

DEODERM by is a Other medication manufactured, distributed, or labeled by LIFSA DRUG LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DEODERM GEL DRESSING WITH HYALURONIC ACID- dressing, wound and burn, occlusive    
LIFSA DRUG LLC

----------

Deoderm Gel Dressing with Hyaluronic Acid

DESCRIPTION

Deoderm Gel is a soothing wound gel that is formulated for the dressing and management of superficial wounds, minor abrasions, pressure ulcers stage II - IV, 1st and 2nd degree burns, including sunburns, and radiation dermatitis. When applied properly to a wound hyaluronic acid adheres to tissue to prevent damage while supplying moisture to the cells. Medium molecular weight polysaccharides in aloe vera moisturize and reduce inflammation.  Proven therapeutic moisturizers, lipids, glycerin and allantoin, relieves dryness.

Deoderm Gel is a non-sterile, off-white, low odor, fragrance free, topical product. The Deoderm Gel forms a physical barrier that helps to maintain a moist wound and skin environment. Deoderm Gel is a prescription medical device.

INDICATIONS FOR USE

Under the supervision of a healthcare professional, Deoderm Gel is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including atopic dermatitis, allergic contact dermatitis and radiation dermatitis. Deoderm Gel also helps to relieve dry, waxy skin by maintaining a moist wound and skin environment, which is beneficial to the healing process.

CONTRAINDICATIONS

Deoderm Gel is contraindicated in persons with a known hypersensitivity to any of the components of the formulation.

WARNINGS

Use only as directed. Keep out of the reach of children. Avoid contact with eyes. For topical use only. Not for ophthalmic use. Do not apply within four hours prior to a radiation session.

PRECAUTIONS AND OBSERVATIONS

• Deoderm Gel does not contain a sunscreen and should not be used prior to extended exposure to the sun.
• If clinical signs of infection are present, appropriate treatment should be initiated; use of Deoderm Gel may be continued during the anti-infective therapy.

INSTRUCTIONS FOR USE

Dispense Deoderm Gel into palm of hand and apply to affected area 3 times per day, or as directed by a physician. Massage gently into the skin until completely absorbed. If the skin is broken, cover with appropriate dressing Deoderm Gel is non-sterile.

INGREDIENTS

Allantoin
Aloe Barbadensis Leaf Extract
Caprylic/Capric Triglyceride
Carbomer
Ceteareth 20
Cetearyl Alcohol
Diazolidinyl Urea & Iodopropynyl Butylcarbamate
Dimethicone
Glycerin
Glycol Stearate
Hyaluronic Acid
Isopropyl Palmitate
Olea Europaea (Olive) Oil
Propylene Glycol
Tetrasodium EDTA
Triethanolamine
Water

HOW SUPPLIED

Deoderm Gel is available in 30g commercial pump dispenser.

CAUTION: Federal law restricts this device to sale by or on the order of a physician or other licensed health care practitioner.

Store between 59°F - 86°F (15°C - 30°C).

MANUFACTURED FOR:

Lifsa Drugs LLC
New Brunswick, NJ 08901

PRINCIPAL DISPLAY PANEL

DEODERM GEL

NET WEIGHT: 30G

NDC: 72336-054-01

DEODERM  GEL DRESSING WITH HYALURONIC ACID
dressing, wound and burn, occlusive

Product Information
Product Type	PRESCRIPTION MEDICAL DEVICE	Item Code (Source)	NHRIC:72336-054

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
ALOE VERA LEAF (UNII: ZY81Z83H0X)
GLYCERIN (UNII: PDC6A3C0OX)
OLIVE OIL (UNII: 6UYK2W1W1E)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
DIMETHICONE (UNII: 92RU3N3Y1O)
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)
POLYOXYL 20 CETOSTEARYL ETHER (UNII: YRC528SWUY)
HYALURONIC ACID (UNII: S270N0TRQY)
GLYCOL STEARATE (UNII: 0324G66D0E)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
ALLANTOIN (UNII: 344S277G0Z)
ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)
TROLAMINE (UNII: 9O3K93S3TK)
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)
DIAZOLIDINYL UREA (UNII: H5RIZ3MPW4)
IODOPROPYNYL BUTYLCARBAMATE (UNII: 603P14DHEB)
EDETATE SODIUM (UNII: MP1J8420LU)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NHRIC:72336-054-01	30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
exempt device	MDA	06/12/2020	06/12/2020

Labeler - LIFSA DRUG LLC (081205160)

Revised: 10/2021

Document Id: cd9286ca-5206-4898-a085-a34bae3e726f

69404-2

Set id: 9e0cd4f7-b041-46fe-9415-2b3e271dcb9b

Version: 3

Effective Time: 20211018